Catalyst Wire Dossier Catalyst Wire Dossier

Rituxan Hycela

rituximab/hyaluronidase · Genentech (Roche)
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Rituxan Hycela, covering 2017-06-22 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL [Phase 2]

See pricing